Revolutionizing Biomarker Discovery with a Excessive-Throughput Immunoproteomic PlatformBOSTON, July 30, 2024 /PRNewswire/ -- Sengenics Company LLC is proud to announce the launch of i-Ome...
About 240,000 new instances of breast most cancers are recognized in girls within the U.S. every year, which implies it’s nonetheless the second-leading...
